Thanks to synthetic biotechnology such as genetic engineering, recombinant collagen has shown great potential in fields such as medicine, beauty, and functional foods due to its high biocompatibility, high activity and purity, and low immunogenicity.
1、 The recombinant collagen market is expected to experience an explosive period in 2025.
At the end of 2024, the recombinant collagen market has ushered in new development opportunities. The establishment of a joint venture between Shangmei Corporation and Juyuan Biotechnology marks a further expansion of the recombinant collagen market.
It is expected that by 2025, the recombinant collagen market will experience an explosive period and become a new star in the beauty and medical fields.
Recombinant collagen, due to its low rejection rate and high purity, is gradually replacing traditional animal derived collagen. The market size is expected to reach 108.3 billion yuan, accounting for 62.3% of the collagen market size.
2、 A large number of domestic and foreign enterprises are conducting market layout
Currently, domestic and foreign beauty giants such as L'Oreal, Est é e Lauder, and L'Oreal are expanding into the recombinant collagen market, launching new products and brands containing recombinant collagen.
Shangmei Corporation plans to launch a new brand, Jiaoyuanli, in 2025, focusing on the overall collagen ecology of the skin. It will use Nobel Prize gene editing technology to specifically select and recombine 100% human V collagen.
As the pioneer of global recombinant humanized collagen biomaterials, Jinbo Biotechnology's technological breakthroughs not only fill the gap in the global field, but also help Shanxi Province transform from a "coal dominant" to a high-tech industry.
3、 Breakthroughs in scientific research and technology will accelerate the development of the recombinant collagen market
The continuous breakthroughs in scientific research technology provide strong support for the development of the recombinant collagen market.
For example, Giant Biotechnology has solved the efficiency problem that previously hindered the production of recombinant collagen protein globally through high-density fermentation and efficient separation and purification technology.
Resulting in a purity of 99.9% for recombinant collagen protein and a bacterial endotoxin concentration of less than 0.1E/mg, significantly better than the industry standard for medical grade materials.
4、 In the future, there will be a huge demand for the light medical beauty market, and the open attitude of consumers towards light medical beauty provides a good opportunity for the development of the recombinant collagen market.
Recombinant collagen, as a biomaterial with supporting and filling properties, has shown great potential in the field of medical aesthetics. With the peak approval of three types of equipment certificates in 2025, the recombinant collagen market will usher in a new round of development opportunities.
In the future, the ecosystem of the recombinant collagen industry will move forward amidst controversy. From upstream raw material suppliers to brand enterprises, they are all promoting innovation and progress in the recombinant collagen industry through research investment, brand building, and other means.
Although there are still controversies and doubts about recombinant collagen in the market, as an emerging biomaterial, recombinant collagen, driven by the core strength of local enterprises, will usher in a brighter future.
